Last $46.96 USD
Change Today -2.36 / -4.79%
Volume 2.0M
INCY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roy A. Whitfield

Co-Founder and Director, Incyte Corporation
AgeTotal Calculated CompensationThis person is connected to 62 board members in 6 different organizations across 8 different industries.

See Board Relationships
59$249,380

Background*

Mr. Roy A. Whitfield served as Chief Executive Officer of Hexagen PLC. Mr. Whitfield has over 20 years of management and governance experience in the biotechnology industry. He co-founded Incyte Corp., (formerly, Incyte Genomics, Inc.) in 1991 and served as its Chairman of the Board from November 2001 to June 24, 2003, Chief Executive Officer from June 1993 to November 2001, President from June 1991 to January 1997 and Treasurer from April 1991 to October 1995. At Incyte, ...

Read Full Background

Corporate Headquarters*

Experimental Station
Wilmington, Delaware 19880

United States

Phone: 302-498-6700
Fax: --

Board Members Memberships*

Former Director
Former Director
Director
1991-Present
Co-Founder and Director
1997-N/A
Former Director
2000-Present
Independent Director and Chairman of Nominating & Corporate Governance Committee
2005-N/A
Director and chairman of Science and Business Advisory Board
2006-Present
Director, Member of Audit Committee and Member of Compensation Committee
2006-Present
Executive Chairman
2007-Present
Director, Member of Compensation Committee and Member of Audit Committee

Education*

BS
University of Oxford
MBA
The Board of Trustees of The Leland Stanford Junior University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$48,668
Total Calculated Compensation$249,380
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INCY:US $46.96 USD -2.36

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman of the Board, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
$1.7M
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
Werner Lanthaler MBA,MPAChief Executive Officer
Evotec AG
€601.0K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INCYTE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.